FDA Investigator Anthony J Lagreca
Anthony J Lagreca has conducted inspections on 2 sites in 1 countries as of 19 Jun 2009. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
2
Last Inspection Date:
19 Jun 2009
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Anthony J Lagreca:
Bryce A Hammer,
Erika V Butler,
Frank L Cordova,
Grace E Mcnally,
Hanna L Potter,
Justin R Carr,
Karen G Hirshfield,
Katherine Szestypalow,
Kent C Faul,
Kimberley A Hoefen,
Linda M Cheny,
Marie B Buen Bigornia,
Matthew J Hansen,
Matthew R Dionne,
Michael A Charles,
Michael J Kuchta,
Michael R Goga,
Nathan M Jornod,
Nayan J Patel,
Patricia A Brown,
Patricia A Cortez,
Thai T Duong,
Theressa B Smith,
Toni L Morales,
Zachary A Bogorad
Anthony J Lagreca's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2009 | FDA 483 | New Vistas Inc. - Form 483, 2009-06-25 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more